{
  "id": "53636e727d100faa0900000d",
  "type": "yesno",
  "question": "Are microRNA (miR) regulated through DNA methylation of their promoters?",
  "ideal_answer": "Dysregulation of miRNA expression involved in cancer and Alzheimer's disease can be triggered by multiple mechanisms including aberrant DNA methylation of the miRNA gene promoter. Epigenetic dysregulation of tumor-suppressor miRNA genes by promoter DNA methylation has been implicated in human cancers, including multiple myeloma (MM).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18677110",
    "http://www.ncbi.nlm.nih.gov/pubmed/19807731",
    "http://www.ncbi.nlm.nih.gov/pubmed/23229728",
    "http://www.ncbi.nlm.nih.gov/pubmed/23153241",
    "http://www.ncbi.nlm.nih.gov/pubmed/24238656",
    "http://www.ncbi.nlm.nih.gov/pubmed/23707524",
    "http://www.ncbi.nlm.nih.gov/pubmed/22715154",
    "http://www.ncbi.nlm.nih.gov/pubmed/22710432",
    "http://www.ncbi.nlm.nih.gov/pubmed/23658527"
  ],
  "snippets": [
    {
      "text": "We found that Tcf3 down-regulation in the context of constitutively active Wnt signaling does not result from promoter DNA methylation but is likely to be caused by a plethora of mechanisms at both the RNA and protein level as shown by the observed decrease in activating histone marks (H3K4me3 and H3-acetylation) and the upregulation of miR-211, a novel Wnt-regulated microRNA that targets Tcf3 and attenuates early neural differentiation in mouse ESCs",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23658527",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19807731",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Whereas a CpG island was identified within the promoter element of MIR22, no promoter DNA methylation was detected in these cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19807731",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "xtensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22710432",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Integration of DNA methylation and miRNA promoter data led to the identification of 128 recurrent miRNA targets for aberrant promoter DNA methylation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22710432",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Together, our findings characterize the role of epigenetic changes in the regulation of miRNA transcription and create a repository of disease-specific promoter regions that may provide additional insights into the pathogenesis of CLL",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22710432",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NA methylation of microRNA genes in multiple myeloma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22715154",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recently, epigenetic dysregulation of tumor-suppressor miRNA genes by promoter DNA methylation has been implicated in human cancers, including multiple myeloma (MM)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22715154",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ethylation of tumor suppressor microRNAs",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23153241",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Dysregulation of miRNA expression involved in cancer can be triggered by multiple mechanisms including aberrant DNA methylation of the miRNA gene promoter",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23153241",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of note, DNA methylation of tumor suppressor miRNAs has been implicated in various human cancers",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23153241",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Moreover, miRNA silencing mediated by aberrant promoter DNA methylation can potentially be reversed by hypomethylating agents, and hence may pose a new therapeutic target in cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23153241",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " In this review, the authors will focus on the aberrant methylation of miRNAs in the pathogenesis of lymphoid malignancies including chronic lymphocytic leukemia, multiple myeloma and acute lymphoblastic leukemia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23153241",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we review those miRNAs implicated in AD that are regulated by promoter DNA methylation and/or chromatin modifications and, which frequently direct the expression of constituents of the epigenetic machinery, concluding with the delineation of a complex epigenetic-miRNA regulatory network and its alterations in AD",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24238656",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Furthermore, we also discuss epigenetic dysregulation of tumor-suppressor miRNA genes by promoter DNA methylation and the interaction of DNA methylation with miRNAs involved in the regulation of HSC activation and liver fibrosi",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Instead, the cell type-specific silencing of these genes is due to enhanced p21 mRNA degradation, 14-3-3sigma promoter DNA methylation and reduced processing of the miR-34a primary transcript",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18677110",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Some tumor-suppressive miRNAs are known to be epigenetically silenced by promoter DNA methylation in cancer",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229728",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the present study, we aimed to identify miRNA genes that are silenced by DNA hypermethylation in hepatocellular carcinoma (HCC)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229728",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It was found that miR-335, which is harbored within an intron of its protein-coding host gene, MEST, was downregulated by aberrant promoter hypermethylation via further methylation assays, including methylation-specific PCR, combined bisulfite and restriction analysis, bisulfite sequencing analysis and 5-aza-2'-deoxycytidine treatment",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229728",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "he levels of miR-335/MEST methylation were significantly higher in 18 (90%) out of 20 primary HCC tumors, compared to their non-tumor tissue counterparts (P<0.001)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229728",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In conclusion, our results indicate that expression of miR-335 is reduced by aberrant DNA methylation in HCC.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229728",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012926",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D035683",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006306",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019175",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0044030",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004247"
  ],
  "exact_answer": "Yes"
}